LANTHEUS HOLDINGS INC (LNTH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LNTH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LNTH | Member; Director | 68 | ["commercial and operational management background", "extensive experience with radiopharmaceutical products", "Co-Founder and former Chief Operating Officer of Advanced Accelerator Applications S.A.", "Director, Evergreen Theragnostics, Inc.", "Director, Progenics Pharmaceuticals, Inc.", "Doctorate, Universit\u00e9 of Pharmacy of Grenoble France"] | ["Member", "Science and Technology Committee", "Talent and Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Gérard Ber Director since 2020 Independent 68 years old Committees: Talent and Compensation Committee Science and Technology Committee Specific Expertise: Dr. Ber was chosen as a Director because of his commercial and operational management background and extensive experience with radiopharmaceutical products. Career Highlights: Co-Founder and former Chief Operating Officer of Advanced Accelerator Applications S.A. (2002 until January 2018) Other Boards: Prior Director, Evergreen Theragnostics, Inc. Director, Progenics Pharmaceuticals, Inc. Education: Doctorate, Université of Pharmacy of Grenoble France